TÜV SÜD issues the first IVDR certificate for an IVD companion diagnostic (CDx) device
Notified Body TÜV SÜD Product Service GmbH is happy to announce the issue of the world’s first CDx certificate in accord…
Notified Body TÜV SÜD Product Service GmbH is happy to announce the issue of the world’s first CDx certificate in accord…
ImmunOs Therapeutics AG, a Swiss biotechnology company developing a new class of biologics for the treatment of cancer a…
Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunol…
Multiple studies presented in virtual 2020 ASCO Annual Meeting highlight the impact of QIAGEN’s Sample to Insight portfo…
Their ideas fight complicated urinary tract infections, ensure sustainable natural resource exploration and supply, and…
GELITA’s bone health ingredient FORTIBONE® has received the German Innovation Award 2019 in the “Excellence in B2B, Phar…
Safety, tolerability and efficacy of resminostat in combination with S-1 chemotherapy will be investigated in various do…
4SC AG (Frankfurt, Prime Standard: ISIN DE000A14KL72, VSC), a discovery and development company of targeted small molecu…
More than 100 business developers and other decision makers from the pharmaceutical and biotechnology industry and inves…
. - Phase I confirms safety and tolerability of resminostat/docetaxel combination in the planned dose regimen in Asian…